Petros Pharmaceuticals: Invitation to the Q3 Virtual Investor Summit

New Jersey and Pennsylvania--(Newsfile Corp. - August 11, 2021) - Petros Pharmaceuticals (NASDAQ: PTPI) today announced that Fady Boctor, President, Chief Commercial Officer will be attending the Q3 Virtual Investor Summit.

About Petros Pharmaceuticals

Petros Pharmaceuticals aims to be a premier Men’s health therapeutics company, prescription and over-the-counter (OTC), with a currently commercialized multi-product asset portfolio and a pre-clinical asset in development for the potential treatment of Peyronie’s disease.

For further information:

Petros Pharmaceuticals
Fady Boctor
2153706927
fboctor@petrospharma.com

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration: please click here: Complimentary Investor Registration.

Contact:

Sasha Murray at sasha@investorsummitgroup.com